Gly-Sal 2-2 Pads

Manufacturer
Topiderm, Inc. | Topix Pharmaceuticals, Inc.
Effective date
2023-02-16
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:57:08

Label at a glance#

ProductGly-Sal 2-2 Pads
Active ingredientSALICYLIC ACID
Label structure8 sections

Indications and uses

Cleansing pads for the treatment of acne.

Dosage and administration

Wipe the entire affected area with a pad one to three times daily Because excessive drying of the skin can occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a physician If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid USP, 2%

Purpose

OTC - PURPOSE SECTION

Acne medication

Uses

INDICATIONS & USAGE SECTION

Cleansing pads for the treatment of acne.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Wipe the entire affected area with a pad one to three times daily
  • Because excessive drying of the skin can occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a physician
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Warnings

WARNINGS SECTION

  • For external use only
  • Keep away from eyes, lips, and mouth

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children
  • If irritation develops, discontinue use and consult a doctor
  • Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor
  • If swallowed, seek professional assistance or contact a Poison Control Center immediately
  • Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter because some individuals may be more sensitive to sunlight.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Ammonium Hydroxide, Camellia Sinensis Leaf Extract, Disodium EDTA, Glycolic Acid, Hamamelis Virginiana (Witch Hazel) Water, Imidazolidinyl Urea, Polysorbate 20, Purified Water, Sodium Benzoate.

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

REPLENiX®
ACNE SOLUTIONS

Topix Pharmaceuticals, Inc.
N. Amityville, NY 11701

Gly/Sal® 2-2
Pads

Glycolic Acid 2%
Salicylic Acid USP, 2%

60 Pads

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label
PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
797892salicylic acid 2 % Medicated PadPSN2
797892salicylic acid 20 MG/ML Medicated PadSCD2
797892salicylic acid 2 % Medicated PadSY2
797892salicylic acid 2 % Topical SwabSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51326-923-01Gly-Sal 2-2 Pads60 in 1 JARCLOTH602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51326-923GLY-SAL 2-2 PADS (SALICYLIC ACID) CLOTH [TOPIDERM, INC.]2Current NDC, 1 package rows20231021_a92a9ffb-5c5b-43a4-b669-04667324920b.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51326-92351326-923-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gly-Sal 2-2 PadsSALICYLIC ACIDTopiderm, Inc.a92a9ffb-5c5b-43a4-b669-04667324920b2023-02-16WarningsExact identifier
ndc (package): 51326-923-01
ndc (product): 51326-923
ndc11 (package): 51326092301
spl id: 45299656-b734-4edb-a780-e99a5a333043
spl set id: a92a9ffb-5c5b-43a4-b669-04667324920b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.